Literature DB >> 22858046

Corneal repair by human corneal keratocyte-reprogrammed iPSCs and amphiphatic carboxymethyl-hexanoyl chitosan hydrogel.

Yueh Chien1, Yi-Wen Liao, Dean-Mo Liu, Heng-Liang Lin, Shih-Jen Chen, Hen-Li Chen, Chi-Hsien Peng, Chang-Min Liang, Chung-Yuan Mou, Shih-Hwa Chiou.   

Abstract

Induced pluripotent stem cells (iPSCs) have promising potential in regenerative medicine, but whether iPSCs can promote corneal reconstruction remains undetermined. In this study, we successfully reprogrammed human corneal keratocytes into iPSCs. To prevent feeder cell contamination, these iPSCs were cultured onto a serum- and feeder-free system in which they remained stable through 30 passages and showed ESC-like pluripotent property. To investigate the availability of iPSCs as bioengineered substitutes in corneal repair, we developed a thermo-gelling injectable amphiphatic carboxymethyl-hexanoyl chitosan (CHC) nanoscale hydrogel and found that such gel increased the viability and CD44+proportion of iPSCs, and maintained their stem-cell like gene expression, in the presence of culture media. Combined treatment of iPSC with CHC hydrogel (iPSC/CHC hydrogel) facilitated wound healing in surgical abrasion-injured corneas. In severe corneal damage induced by alkaline, iPSC/CHC hydrogel enhanced corneal reconstruction by downregulating oxidative stress and recruiting endogenous epithelial cells to restore corneal epithelial thickness. Therefore, we demonstrated that these human keratocyte-reprogrammed iPSCs, when combined with CHC hydrogel, can be used as a rapid delivery system to efficiently enhance corneal wound healing. In addition, iPSCs reprogrammed from corneal surgical residues may serve as an alternative cell source for personalized therapies for human corneal damage.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22858046     DOI: 10.1016/j.biomaterials.2012.07.029

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  20 in total

Review 1.  Research on induced pluripotent stem cells and the application in ocular tissues.

Authors:  Xiao-Ling Guo; Jian-Su Chen
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

Review 2.  Pluripotent Stem Cells and Other Innovative Strategies for the Treatment of Ocular Surface Diseases.

Authors:  Johanna Erbani; Daniel Aberdam; Jerome Larghero; Valérie Vanneaux
Journal:  Stem Cell Rev Rep       Date:  2016-04       Impact factor: 5.739

3.  Cytotoxicity of pilocarpine to human corneal stromal cells and its underlying cytotoxic mechanisms.

Authors:  Xiao-Long Yuan; Qian Wen; Meng-Yu Zhang; Ting-Jun Fan
Journal:  Int J Ophthalmol       Date:  2016-04-18       Impact factor: 1.779

4.  Induced pluripotent stem cells, form in vitro tissue engineering to in vivo allogeneic transplantation.

Authors:  Yi-Chen Li; Kai Zhu; Tai-Horng Young
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

5.  Advanced glycation end products delay corneal epithelial wound healing through reactive oxygen species generation.

Authors:  Long Shi; Hongmei Chen; Xiaoming Yu; Xinyi Wu
Journal:  Mol Cell Biochem       Date:  2013-08-18       Impact factor: 3.396

6.  Human fetal keratocytes have multipotent characteristics in the developing avian embryo.

Authors:  Jennifer R Chao; Marianne E Bronner; Peter Y Lwigale
Journal:  Stem Cells Dev       Date:  2013-04-05       Impact factor: 3.272

Review 7.  Injectable hydrogels for ophthalmic applications.

Authors:  Kai Wang; Zongchao Han
Journal:  J Control Release       Date:  2017-10-20       Impact factor: 9.776

Review 8.  Modeling the cornea in 3-dimensions: Current and future perspectives.

Authors:  Tina B McKay; Audrey E K Hutcheon; Xiaoqing Guo; James D Zieske; Dimitrios Karamichos
Journal:  Exp Eye Res       Date:  2020-06-30       Impact factor: 3.770

9.  Keratocytes derived from spheroid culture of corneal stromal cells resemble tissue resident keratocytes.

Authors:  Yong-Soo Byun; Sapna Tibrewal; Eunjae Kim; Lisette Yco; Joy Sarkar; Yair Ivanir; Chia-Yang Liu; Cecile M Sano; Sandeep Jain
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

Review 10.  Potential Role of Induced Pluripotent Stem Cells (IPSCs) for Cell-Based Therapy of the Ocular Surface.

Authors:  Ricardo P Casaroli-Marano; Núria Nieto-Nicolau; Eva M Martínez-Conesa; Michael Edel; Ana B Álvarez-Palomo
Journal:  J Clin Med       Date:  2015-02-12       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.